Amylyx Pharmaceuticals Inc (AMLX)
1.63
-0.02
(-1.21%)
USD |
NASDAQ |
Jun 18, 15:47
Amylyx Pharmaceuticals Total Assets (Quarterly): 417.46M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 417.46M |
December 31, 2023 | 517.45M |
September 30, 2023 | 466.58M |
June 30, 2023 | 453.59M |
March 31, 2023 | 407.96M |
December 31, 2022 | 391.45M |
Date | Value |
---|---|
September 30, 2022 | 181.44M |
June 30, 2022 | 225.24M |
March 31, 2022 | 274.44M |
December 31, 2021 | 105.61M |
September 30, 2021 | 130.46M |
December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.10M
Minimum
Dec 2020
517.45M
Maximum
Dec 2023
298.82M
Average
332.95M
Median
Total Assets (Quarterly) Benchmarks
iRhythm Technologies Inc | 909.76M |
Cassava Sciences Inc | 155.72M |
Bristol-Myers Squibb Co | 99.03B |
Moderna Inc | 16.73B |
InfuSystems Holdings Inc | 104.85M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 93.02M |
Shareholders Equity (Quarterly) | 324.44M |
Current Ratio | 4.480 |